A genome-wide CRISPR activation screen identifies B4GALNT2 as an inhibitory host factor for influenza virus infection

A pliable mediator acts as a functional, rather than an architectural bridge, between promoters and enhancers

Active DNA demethylation promotes cell fate specification and the DNA damage response

Active DNA demethylation promotes cell fate specification and the DNA damage response [PB-Seq]

Base editor induced mutation spectrum in GFP, human ATP1a1, human TP53BP1 and murine MyoD

Capturing pairwise and multi-way chromosomal conformations using C-walks

Cell-type specific gene expression profiling in heterogeneous in vitro cultures using epitope-tagged RPL22

Characterization and bioinformatic filtering of ambient gRNAs in single-cell CRISPR screens using CLEANSER [CRISPR]

Combinatorial genetic strategy accelerates the discovery of cancer genotype-phenotype associations

Comparison of Hi-C results using in-solution versus in-nucleus ligation

Development of a ß-Globin Gene Replacement Strategy as a Therapeutic Approach for ß-Hemoglobinopathies

Genome-wide analysis of histone modification, protein-DNA binding, cytosine methylation and transcriptome data in mouse and human ES cells and pig iPS cells

Histone H2A T120 phophorylation promotes oncogenic transformation via upregulation of cyclin D1y

In vivo adenine base editing of PCSK9 in mice and macaques reduces LDL-cholesterol levels

In vivo adenine base editing of PCSK9 in mice and macaques reduces LDL-cholesterol levels [amplicon-seq]

Internally Calibrated ChIP-seq (ICeChIP-seq) using a large panel of antibodies against H3K4 methylations to measure genome-wide histone modification density in mammalian cells

Intra-Vk Cluster Recombination Shapes the Ig Kappa Locus Repertoire [HTGTS]

Non-Invasive Detection of Allele-Specific CRISPR-SaCas9-KKH Disruption of TOR1A DYT1 Allele in A Xenograft Mouse Model

PAPERCLIP Identifies MicroRNA Targets and a Role of CstF64/64tau in Promoting Non-canonical poly(A) Site Usage.

PD-1/PD-L1 immune checkpoint and p53 loss facilitate tumor progression in activated B cell diffuse large B-cell lymphomas